| Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC) announced today that it has initiated talks with a drug development company pursuing a promising new therapy for Parkinson's disease. The market for Parkinson's disease drugs could reach a value of $3.75 billion by 2015, according to a 2011 report by business info provider Visiongain. New drugs and other products could significantly boost the Parkinson's treatment market and help advance the timeline for a cure...continued RBCC |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment